SHANGPHARMA CORPORATION | 6,895 Euro | +0,011 +0,16 % | |
| WKN: A1C6ZV ISIN: US81943P1049 Ticker-Symbol: N/A | Frankfurt | 28.03.13 | 08:02 Uhr |
Branche PharmaAktienmarkt nicht mehr börsennotiert |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 28.03. | XFRA FRA: DELETION OF INSTRUMENTS FROM XETRA - 28.03.2013 | 110 | Xetra Newsboard | |
| The following instruments on XETRA do have their last trading day on
28.03.2013
Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am
28.03.2013
ISIN Name
CA64127M1059 NEVADA... Mehr lesen zu: XFRA FRA: DELETION OF INSTRUMENTS FROM XETRA - 28.03.2013 | ||||
| 28.03. | ShangPharma Announces Completion of Merger | - | Benzinga.com | |
| 28.03. | ShangPharma Corporation Announces Completion of Merger | 63 | PR Newswire | |
| SHANGHAI, March 28, 2013 /PRNewswire/ -- ShangPharma Corporation (NYSE: SHP) (the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing... Mehr lesen zu: ShangPharma Corporation Announces Completion of Merger | ||||
| 20.03. | ShangPharma (SHP) Shareholders Approve Merger Proposal | - | StreetInsider.com | |
| 20.03. | ShangPharma Shareholders Approve Merger Agreement | - | Benzinga.com | |
| 20.03. | ShangPharma Corporation Announces Shareholders' Approval of Merger Agreement | 54 | PR Newswire | |
| SHANGHAI, March 20, 2013 /PRNewswire/ --ShangPharma Corporation (NYSE: SHP) (the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today... Mehr lesen zu: ShangPharma Corporation Announces Shareholders' Approval of Merger Agreement | ||||
| 25.02. | ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders | 23 | PR Newswire | |
| SHANGHAI, Feb. 25, 2013 /PRNewswire/ -- ShangPharma Corporation (NYSE: SHP) (the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today... Mehr lesen zu: ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders | ||||
| 21.12. | ShangPharma Enters Deal to Go Private at $9/ADS | - | Benzinga.com | |
| 21.12. | ShangPharma (SHP) Enters Deal to Go Private for $9/ADS | - | StreetInsider.com | |
| 21.12. | ShangPharma Corporation Enters into Definitive Merger Agreement for Going Private Transaction | 48 | PR Newswire | |
| SHANGHAI, China, Dec. 21, 2012 /PRNewswire/ -- ShangPharma Corporation (NYSE: SHP) (the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company... Mehr lesen zu: ShangPharma Corporation Enters into Definitive Merger Agreement for Going Private Transaction | ||||
| 20.11. | ShangPharma Announces Third Quarter 2012 Results | 23 | PR Newswire | |
| SHANGHAI, Nov. 20, 2012 /PRNewswire/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development... Mehr lesen zu: ShangPharma Announces Third Quarter 2012 Results | ||||
| 06.11. | ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012 | 19 | PR Newswire | |
| SHANGHAI, Nov. 6, 2012 /PRNewswire/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development... Mehr lesen zu: ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012 | ||||
| 13.09. | ShangPharma and Harbour Antibodies Announce Licensing Agreement | 34 | PR Newswire | |
| SHANGHAI, Sept. 13, 2012 /PRNewswire/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing... Mehr lesen zu: ShangPharma and Harbour Antibodies Announce Licensing Agreement | ||||
| 20.08. | ShangPharma Announces Second Quarter 2012 Results | 64 | PR Newswire | |
| SHANGHAI, Aug. 20, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and... Mehr lesen zu: ShangPharma Announces Second Quarter 2012 Results | ||||
| 06.08. | ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012 | 28 | PR Newswire | |
| SHANGHAI, Aug. 6, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and... Mehr lesen zu: ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012 | ||||
| 03.08. | ShangPharma Independent Committee Appoints Financial Advisor | 38 | PR Newswire | |
| SHANGHAI, Aug. 3, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing... Mehr lesen zu: ShangPharma Independent Committee Appoints Financial Advisor | ||||
| 17.07. | ShangPharma Independent Committee Appoints Chairman and Legal Counsel | 39 | PR Newswire | |
| SHANGHAI, July 17, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development... Mehr lesen zu: ShangPharma Independent Committee Appoints Chairman and Legal Counsel | ||||
| 06.07. | ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS | 79 | PR Newswire | |
| SHANGHAI, July 6, 2012 /PRNewswire-Asia/ --ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing... Mehr lesen zu: ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS | ||||
| 04.06. | ShangPharma and Lilly Celebrate 10 Years of Partnership | 50 | PR Newswire | |
| SHANGHAI, June 4, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE:SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing... Mehr lesen zu: ShangPharma and Lilly Celebrate 10 Years of Partnership | ||||
| 29.05. | ShangPharma Corporation Issues Statement in Response to Name Confusion | 39 | PR Newswire | |
| SHANGHAI, May 29, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development... Mehr lesen zu: ShangPharma Corporation Issues Statement in Response to Name Confusion | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| MERCK KGAA | 122,85 | -0,85 % | Bernecker.tv: Nikkei erreicht ein neues 5-Jahres-Hoch! Aktien: Yingli, Huaneng Power, Yahoo und Merck ... |
| STADA ARZNEIMITTEL | 34,05 | +0,43 % | Stada: Deutsche Bank zeigt Interesse |
| CELESIO | 15,94 | -0,31 % | UBS senkt Celesio auf 'Sell' und Ziel auf 14 Euro |
| GERRESHEIMER | 46,415 | +0,06 % | Gerresheimer AG: Ausbruch aus steigendem Trendkanal (47.66 Euro, Long) |
| NOVARTIS | 57,25 | +0,35 % | Novartis: Neue Studiendaten belegen Wirkung von COPD-Franchise |
